Bio-Rad Laboratories Stock Price and Value Analysis

Should you buy Bio-Rad Laboratories stock? (NYSE:BIO). Let's see how it does in our automated value investing analysis system.

BIO Free Cash Flow Trend

Free Cash Flow trendline for BIO
Free Cash Flow trendline for Bio-Rad Laboratories

Hmm, we can't give any reliable projection for Bio-Rad Laboratories's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the BIO Numbers

BIO Price
(Bio-Rad Laboratories stock price per share)
[?] PE Ratio versus Sector 45% lower than other Healthcare stocks
[?] PE Ratio versus Industry 67% lower than other Diagnostics & Research stocks
[?] Cash Yield 0.74%
[?] Free Cash Flow Jitter 180%

Is Bio-Rad Laboratories Stock on Sale?

Based on our analysis, we believe that you should not buy Bio-Rad Laboratories right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy BIO Stock?

Does Bio-Rad Laboratories have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.